It is in the ASCO poster. Under key eligibility criteria. Specifically lists all 10 patients dosed so far at that point, the cohort number, age, sex, race, dosing level, number of cycles, ethinicity, and specific tumor of each patient. That looks like where Allan Harris got his info.

http://cellceutix.com/wp-content/uploads/2012...-FINAL.pdf